Two Sigma Advisers’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,400
| Closed | -$477K | – | 2550 |
|
|
2024
Q4 | $477K | Sell |
16,400
-65,500
| -80% | -$1.9M | ﹤0.01% | 1792 |
|
|
2024
Q3 | $3.76M | Sell |
81,900
-167,500
| -67% | -$7.69M | 0.01% | 809 |
|
|
2024
Q2 | $10.2M | Sell |
249,400
-204,500
| -45% | -$8.35M | 0.02% | 535 |
|
|
2024
Q1 | $11.6M | Sell |
453,900
-50,200
| -10% | -$1.28M | 0.03% | 490 |
|
|
2023
Q4 | $4.56M | Sell |
504,100
-35,300
| -7% | -$319K | 0.01% | 851 |
|
|
2023
Q3 | $3.44M | Buy |
539,400
+191,900
| +55% | +$1.22M | 0.01% | 912 |
|
|
2023
Q2 | $3.85M | Buy |
347,500
+206,300
| +146% | +$2.29M | 0.01% | 877 |
|
|
2023
Q1 | $2.17M | Buy |
141,200
+84,400
| +149% | +$1.3M | 0.01% | 1236 |
|
|
2022
Q4 | $1.26M | Buy |
+56,800
| New | +$1.26M | ﹤0.01% | 1462 |
|